AuntMinnie
  • Europe
  • Clinical News
  • Informatics
  • Industry News
  • Practice Management
  • Education
  • Subspecialties
  • More
  • Sign In
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcast Network
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
  • RPT Tracker
Clinical News
  • CT
  • Digital X-Ray
  • Interventional
  • Molecular Imaging
  • MRI
  • Radiation Oncology/Therapy
  • Ultrasound
  • Womens Imaging
Imaging Informatics
  • Advanced Visualization
  • Enterprise Imaging
  • AI
  • Cybersecurity
Industry News
  • Installations
  • Product News
  • Regulatory
  • M&A
  • Market Analysis
Practice Management
  • Administration
  • Associations
  • Careers
  • Equity & Inclusion
  • Legislation
  • Medicolegal
  • Patient Safety
  • Radiologic Technologist
  • Service
  • Salary Scan
Resources
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcast Network
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
  • RPT Tracker
User Tools
  • Sign In
More
  • About Us
  • Advertising
  • Help
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon
  • Europe
  • Clinical News
    • CT
    • Digital X-Ray
    • Interventional
    • Molecular Imaging
    • MRI
    • Radiation Oncology/Therapy
    • Ultrasound
    • Womens Imaging
  • Informatics
    • Advanced Visualization
    • Enterprise Imaging
    • AI
    • Cybersecurity
  • Industry News
    • Installations
    • Product News
    • Regulatory
    • M&A
    • Market Analysis
  • Practice Management
    • Administration
    • Associations
    • Careers
    • Equity & Inclusion
    • Legislation
    • Medicolegal
    • Patient Safety
    • Radiologic Technologist
    • Service
    • Salary Scan
  • Education
    • Medical Students
    • Residents/Fellows
  • Subspecialties
    • Breast Imaging
    • CV
    • Chest
    • Emergency
    • GI
    • GU
    • Head & Neck
    • Interventional
    • Physics
    • MSK
    • Neuro
    • Nuclear
    • Pediatric
    • Radiation Oncology
  • More
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcast Network
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
  • RPT Tracker
  • Sign In
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon

Paul Davis

[email protected]
Home
Responsive - Making the most of the new banner ad formats
August 5, 2014
Page Layout Showing A Portrait Ad And Its Expansion Dimensions
Home
Responsive - The Power of Landing Pages
August 5, 2014
2015 06 24 17 50 06 429 Inline
Home
Responsive - 7 Deadly Sins of Landing Page Design
August 5, 2014
Home
Responsive - 5 Short Videos to help you improve your eBroadcasts
August 5, 2014
Home
Mismatched Goals
June 29, 2009
Home
Lost in Translation...
February 5, 2008
2008 03 14 14 48 17 706
Home
Agents of Change: The new wave of crawlers, spiders and bots
March 13, 2006
Home
Defining your success
June 7, 2005
Home
Defining your success
June 5, 2005
Industry News
Rich Media: The power of being rich
March 30, 2005
Previous Page
Page 2 of 3
Next Page
Top Stories
Cardiac stress test imaging comparison showing DeepAC and CT-based attenuation correction scans for two patients with quantitative perfusion data.
Molecular Imaging
AI-driven cardiac PET attenuation correction shows promise
The algorithm could offer a “practical alternative in cardiac PET,” researchers noted.
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Interventional
Image-guided focal laser ablation effective for prostate cancer
Asco Thumb
CT
ASCO: With help from AI, interventions boost lung cancer screening
2260299 Philips 01 Aunt Minnie Leadgen Newsletter Banner 300x250 Static
Imaging Informatics
Philips Interactive Multimedia Reporting: Where Insight Meets Impact
David Vining Md Anderson Longitudinal Record Imr 2026
Imaging Informatics
Radiologists estimate time savings with advanced radiology reports
More in Home
SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
By Amerigo Allegretto
A theranostic approach could help improve PET imaging for neuroendocrine prostate cancer care.
June 2, 2026
RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.
ASCO: Use of GLP-1 drugs linked to lower breast cancer cases
By Erik L. Ridley
A large retrospective study found sharply lower incidence of breast cancer among women who had received GLP-1 drugs.
June 2, 2026
Asco Thumb
SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma
By Liz Carey
Researchers aim for "more precise molecular map" for kidney cancer.
June 1, 2026
A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.
SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater
By Kate Madden Yee
An increase in the use of radionuclide therapy has added burden to wastewater management systems.
June 1, 2026
Snmmi Thumb
SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year
By Will Morton
F-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.
June 1, 2026
(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.
SNMMI: Novel radiotracer effectively images overactive adrenal glands
By Liz Carey
University of Michigan researchers report on first-in-human study of SOAT1-targeted nevanimibe C-11.
June 1, 2026
Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.
SNMMI: Mouaz Al-Mallah discusses cardiac PET
By Will Morton
In this interview, Mouaz Al-Mallah, MD, discusses cardiac PET imaging, including new efforts to create more access for patients and the impact of new radiotracers.
June 1, 2026
Mouaz Al Mallah Thumb1
ASCO: Proton therapy, IMRT both work well for prostate cancer
By Erik L. Ridley
Both modalities yielded similar outcomes, according to preliminary results from a large, prospective trial.
June 1, 2026
Asco Thumb
SNMMI: Point-of-care PET system may guide interventional procedures
By Amerigo Allegretto
A portable, point-of-care PET system showed success in imaging organs and may be helpful in interventional guidance.
June 1, 2026
(a) Benchtop portable POC-PET prototype system. (b) Phantom imaging experiment setup. (c) Comparison of conventional full-data MLEM reconstruction with incremental OSEM reconstruction.
SNMMI: Brain-dedicated PET scanner cuts claustrophobia, boosts comfort
By Kate Madden Yee
The findings "support the use of brain-dedicated PET scanners as a patient-centered alternative," researchers wrote.
June 1, 2026
Snmmi Thumb
SNMMI: PET tracer detects CTE tau pathology in living patients
By Kate Madden Yee
Study findings suggest "a clinical role for PET in traumatic brain injury and sports- and military-related neurodegeneration."
May 31, 2026
Parametric maps obtained with SRTM2 (cerebellum grey matter as reference) for the group of healthy participants (top) and from one representative participant with suspected CTE (bottom). CTE: chronic traumatic encephalopathy.
SNMMI: SPECT/CT tracer shows promise in interstitial lung disease
By Will Morton
Differentiating between fibrotic scarring and inflammation stages of disease is critical so that physicians can determine what treatment is best for the patient.
May 31, 2026
Sample images from each participant group: A: CT only; B: fused Tc-99m maraciclatide SPECT/CT.
Previous Page
Page 2 of 231
Next Page
AuntMinnie
Topics
  • Clinical News
  • Imaging Informatics
  • Industry News
  • Practice Management
  • Radiology Education
  • Subspecialties
Resources
  • Board Review
  • CME
  • Careers
  • Cases
  • Conferences
  • Videos
  • Webinars
  • Podcast Network
  • Advertising
  • Buyer's Guide
  • Vendors
  • Minnies
  • RPT Tracker
More
  • About Us
  • Advertising
  • Help
Follow AuntMinnie
Facebook iconTwitter X icon LinkedIn iconInstagram icon
  1. Privacy Policy
  2. Privacy Settings
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
  6. Home
© 2026 Science and Medicine Group. All rights reserved.